Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts

Stroke

Volumn 41, Issue 11, 2010, Pages 2587-2591

  Lee, Soo Joo ^a   Saver, Jeffrey L ^b   Liebeskind, David S ^b   Ali, Latisha ^b   Ovbiagele, Bruce ^b   Kim, Doojin ^b   Vespa, Paul ^b   Froehler, Michael ^b   Tenser, Matthew ^b   Gadhia, Jignesh ^b   Starkman, Sidney ^b  

^a Eulji University   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

fibrinolysis; intracranial hemorrhage; lacunar infarction; tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; ATAXIA; BRAIN ARTERY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; DRUG SAFETY; DYSARTHRIA; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEMIPARESIS; HEMORRHAGIC TRANSFORMATION; HUMAN; ISCHEMIA; LACUNAR CLINICAL SYDROME; LACUNAR CLINICAL SYNDROME; LARGE ARTERY ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SENSORIMOTOR FUNCTION; SINGLE PENETRATOR ARTERY; SINGLE PENETRATOR ARTERY ISCHEMIA; STROKE;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL ARTERIES; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; DIAGNOSTIC IMAGING; FEMALE; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78149324168     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.586248     Document Type: Article

References (14)

1. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol. 2008;63:52-60.
2. Singer OC, Kurre W, Humpich MC, Lorenz MW, Kastrup A, Liebeskind DS, Thomalla G, Fiehler J, Berkefeld J, Neumann-Haefelin T. Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWI-ASPECTS. Stroke. 2009;40:2743-2748.
3. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
4. Larrue V, von Kummer R, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32: 438-441.
5. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SIST-MOST): an observational study. Lancet. 2007; 369:275-282.
6. Berger C, Fiorelli M, Steiner T, Schabitz W-R, Bozzao L, Bluhmki E, Hacke W, von Kummer R. Hemorrhagic transformation of ischemic brain tissue: Asymptomatic or symptomatic? Stroke. 2001;32:1330-1335.
7. Madden KP, Karanjia PN, Adams HP Jr, Clarke WR. Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in acute stroke treatment. Neurology. 1995;45:1975-1979.
8. Gan R, Sacco RL, Kargman DE, Roberts JK, Boden-Albala B, Gu Q. Testing the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology. 1997;48:1204-1211.
9. Toni D, Iweins F, von Kummer R, Busse O, Bogousslavsky J, Falcou A, Lesaffre E, Lenzi GL. Identification of lacunar infarcts before thrombolysis in the ECASS I study. Neurology. 2000;54:684-688.
10. Toni D, Del Duca R, Fiorelli M, Sacchetti ML, Bastianello S, Giubilei F, Martinazzo C, Argentino C. Pure motor hemiparesis and sensorimotor stroke. Accuracy of very early clinical diagnosis of lacunar strokes. Stroke. 1994;25:92-96.
11. Cocho D, Belvis R, Marti-Fabregas J, Bravo Y, Aleu A, Pagonabarraga J, Molina-Porcel L, Diaz-Manera J, San Roman L, Martinez-Lage M, Martinez A, Moreno M, Marti-Vilalta JL. Does thrombolysis benefit patients with lacunar syndrome? Eur Neurol. 2006;55:70-73.
12. Hwang YH, Seo JG, Lee HW, Park SP, Suh CK. Early neurological deterioration following intravenous recombinant tissue plasminogen activator therapy in patients with acute lacunar stroke. Cerebrovasc Dis. 2008;26:355-359
13. The NINDS tPA Stroke Study Group. Intracerebral hemorrhage after intravenous tPA therapy for ischemic stroke. Stroke. 1997;28:2109-2118.
14. Barber PA, Demchuk AM, Zhang J, Buchan AM, ASPECT study group. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet. 2000;355:1670-1674.